These Biotech ETFs Gain Access To A Broader Array Of Biotech Companies

“Last week a number of biotech players, including Millipore (MIL), OSI Pharmaceuticals (OSIP), Intermune (ITMN) and Sequenom (SQNM) turned in double-digit gains in the volatile health care subsector. On the other side, health care stocks do fall, leaving investors with a bitter taste. For example, when Medivation’s (MDVN) Alzheimer’s drug failed in a late-stage trial last [...]

Related posts:

1. Biotech ETFs May Be Poised For A Great Year Ahead
2. A Cure For Cancer? Look At This Biotech ETF (XBI)
3. A Chance to Catch the Market With Biotech ETFs